ATI RN
ATI Pharmacology Proctored Exam 2019
1. A client is receiving treatment with bevacizumab. Which of the following findings should the nurse monitor?
- A. Hypertension
- B. Hypokalemia
- C. Hyperglycemia
- D. Hypocalcemia
Correct answer: A
Rationale: Correct Answer: A. Bevacizumab is known to cause hypertension as a common adverse effect. The nurse should closely monitor the client's blood pressure to detect and manage this potential side effect promptly. Choice B, hypokalemia, is not typically associated with bevacizumab treatment. Choice C, hyperglycemia, is not a common adverse effect of bevacizumab. Choice D, hypocalcemia, is not a recognized side effect of bevacizumab.
2. A client with Depression has a new prescription for Venlafaxine. For which of the following adverse effects should the nurse monitor this client? (Select all that apply)
- A. Cough
- B. Dizziness
- C. Decreased libido
- D. B and C
Correct answer: D
Rationale: The correct answer is D: 'B and C.' Venlafaxine, a medication used to treat depression, can lead to adverse effects like dizziness and decreased libido. It is important for the nurse to monitor the client for these potential side effects. Cough and alopecia are not typically associated with Venlafaxine. Therefore, choices A (Cough) and C (Decreased libido) are incorrect. Dizziness and decreased libido are the adverse effects that the nurse should focus on when monitoring a client on Venlafaxine treatment.
3. A school-age child has a new prescription for Atomoxetine. The nurse should monitor the client for which of the following adverse effects of this medication?
- A. Kidney toxicity
- B. Liver damage
- C. Seizure activity
- D. Adrenal insufficiency
Correct answer: B
Rationale: Liver damage is an adverse effect of Atomoxetine. The nurse should monitor for manifestations such as jaundice, upper abdominal tenderness, darkening of urine, and elevated liver enzymes. It is crucial to be vigilant for signs of liver damage to ensure early detection and intervention to prevent further complications. Kidney toxicity is not a common adverse effect of Atomoxetine. Seizure activity and adrenal insufficiency are also not typically associated with this medication.
4. A client reports using over-the-counter calcium carbonate antacid. Which of the following recommendations should the nurse make about taking this medication?
- A. Decrease bulk in the diet to counteract the adverse effect of diarrhea.
- B. Take the medication with dairy products to increase absorption.
- C. Reduce sodium intake.
- D. Drink a glass of water after taking the medication.
Correct answer: D
Rationale: The correct recommendation for taking calcium carbonate antacid is to drink a glass of water after taking the medication. This practice enhances the effectiveness of the antacid by promoting its dissolution and absorption in the stomach, providing relief from symptoms of heartburn and indigestion. Choices A, B, and C are incorrect. Choice A is not relevant as calcium carbonate antacid does not typically cause diarrhea. Choice B is inaccurate as taking calcium carbonate with dairy products may decrease its absorption due to the presence of calcium in both sources. Choice C is unrelated to the administration of calcium carbonate antacid.
5. A client has a new prescription for Filgrastim to treat neutropenia. Which of the following statements should the nurse include?
- A. This medication will help increase your white blood cell count.
- B. This medication will help reduce your risk of infection.
- C. This medication will help improve your red blood cell count.
- D. This medication will help increase your platelet count.
Correct answer: A
Rationale: The correct statement the nurse should include is that 'This medication will help increase your white blood cell count.' Filgrastim is a medication used to stimulate the production of white blood cells, specifically neutrophils, to increase the white blood cell count. This increase in white blood cells helps reduce the risk of infections in clients with neutropenia. Choices B, C, and D are incorrect because Filgrastim specifically targets white blood cells, not red blood cells or platelets.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access